NCT06113276

Brief Summary

Acute respiratory distress syndrome remains a deadly disease with hospital mortality remaining between 40 to 50%. ARDS mortality risk factors have been identified from patient history, common clinical and biological variables in the lung SAFE study. Part of ARDS mortality is attributable to ventilator-induced lung injury (VILI), in relation with inappropriate settings on the ventilator. Tidal hyperinflation and recruitment/derecruitment during lung inflation are 2 identified mechanisms leading to VILI, that may be identified on computed tomography while poorly identified with variables collected at the bedside. The aim of this study is to identify whether tidal hyperinflation identified on computed tomography is a risk factor for ARDS mortality, independently from know bio-clinical risk factors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 6, 2020

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

October 27, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

4 years

First QC Date

October 27, 2023

Last Update Submit

January 30, 2024

Conditions

Keywords

ARDScomputed tomographyalveolar recruitmentPEEPtidal hyperinflation

Outcome Measures

Primary Outcomes (1)

  • Odd ratio of tidal hyperinflation assessed on CT at day-0 as an independent predictor of 90-day mortality

    Tidal hyperinflation is computed as the volume difference of hyperinflated lung (i.e., with CT attenuation between -1000 and -900 Hounsfield units) between and-expiration and end-inspiration at the PEEP level chosen by clinician

    Day-0 (time of realization of CT scan)

Study Arms (1)

tidal hyperinflation

As the study aim to identify whether tidal hyperinflation is an independent predictor for ARDS mortality, and as this variable will be entered as a quantitative predictor in the multivariate model, the study encompass a single group of patient (i.e. all included patients)

Radiation: Low dose computed tomography to evaluate biomechanical parameters in the lung

Interventions

In the participating to the study, response to PEEP increase and tidal inflation are evaluated with a software computing biomechanical parameters (tidal hyperinflation and lung recruitability). Tidal hyperinflation and recruitment are computed on CT images acquired within 72 hours after ARDS onset or with 72h after ECMO onset.

tidal hyperinflation

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be screened from the population of patient hospitalized for ARDS in the participating centers

You may qualify if:

  • Patient aged 15 or older with ARDS according to the Berlin definition
  • invasive mechanical ventilation with PaO2/FiO2 ≤ 300 mm Hg
  • with computed tomography acquired at both end-expiration and end-inspiration, or at both PEEP 5 and 15 cm H2O at end-expiration
  • PEEP setting according to a PEEP/FiO2 table, with secondary adjustment according to hemodynamic tolerance
  • Tidal volume 6 ml/kg of predicted body weight or less

You may not qualify if:

  • Use of contrast agent during computed tomography acquisition
  • ARDS criteria onset since more than 72 hours or ECMO onset since more than 72 hours
  • Proven COPD
  • Pneumothorax or bronchopleural fistula
  • Patient with spontaneous breathing preventing realization of end-expiratory and end-inspiratory pauses
  • Patient under a legal protective measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Service de Médecine Intensive Réanimation Hôpital Michallon - CHU Grenoble Alpes

La Tronche, 38700, France

RECRUITING

Hospices Civils de Lyon - Hôpital de la Croix Rousse - Service de Médecine Intensive Réanimation

Lyon, 69004, France

RECRUITING

Service de Réanimation Polyvalente Centre Hospitalier Lyon Sud Hospices Civils de Lyon

Pierre-Bénite, 69310, France

RECRUITING

Centre Hospitalier Universitaire de Rennes

Rennes, France

RECRUITING

Related Publications (1)

  • Shekarnabi M, Guillien A, Terzi N, Sigaud F, Bitker L, Roux E, Ahaouari T, Serrano EED, Boussel L, Ferretti G, Yonis H, Mezidi M, Noirot I, Chauvelot L, Dhelft F, Gaillet M, Siroux V, Orkisz M, Richard JC, Bayat S. Prognostic value of functional CT imaging in COVID-ARDS: a two-centre prospective observational study. Respir Res. 2025 May 9;26(1):177. doi: 10.1186/s12931-025-03232-7.

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2023

First Posted

November 2, 2023

Study Start

November 6, 2020

Primary Completion

November 1, 2024

Study Completion

May 1, 2025

Last Updated

January 31, 2024

Record last verified: 2024-01

Locations